In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...

Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first ...

The post RFK Jr. Shifts $500 Million From mRNA Research to 'Safer' Vaccines. Does the Data Back That Up? appeared first on Reason.com.

A comprehensive economic analysis of 2023-2024 COVID-19 vaccination shows that older adults see the greatest payoff, largely due to money saved from avoided hospital stays and medical care.